NCT07638371

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-06-09Est. Completion: 2030-06-09

Enrollment target: 16 participants

Locations

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Cancer Center @ Nassau (Limited Protocol Activities), Uniondale, New York, United States

Contact

Adam Schoenfeld, MDschoenfa@mskcc.org

Other microbiome trials you might be interested in

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianPhase 1Recruiting

BRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial AdenocarcinomaEstrogen Receptor NegativeHER2/Neu NegativeHigh Grade Ovarian Serous AdenocarcinomaProgesterone Receptor NegativeRecurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7Stage IV Uterine Corpus Cancer AJCC v7Triple-Negative Breast Carcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.